ADMINISTRATION S EFFECTS OF L-ARGININE AND N-ACETYLCYSTEINE ON NITRIC OXIDE S PRODUCTION AND ON BLOOD PRESSURE IN DIABETIC AND HYPERTENSIVE PATIENTS.

• Conditions: MedDRA version: 9.1Level: LLTClassification code 10004254Term: Benign essential hypertension; MedDRA version: 9.1Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependent; DIABETES MELLITUS AND HYPERTENSION

• Registration Number: EUCTR2004-004203-38-IT
• Lead Sponsor: AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01-05
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):